Chuma Makoto 中馬誠

… Alternative Names

Makoto Chuma 中馬誠

CHUMA Makoto 中馬誠

Less

Researcher Number	30360910
Other IDs
External Links
Affiliation (based on the past Project Information) *help	2022 – 2023: 横浜市立大学, 附属市民総合医療センター, 准教授 2021: 横浜市立大学, 附属市民総合医療センター, 診療教授 2016: 横浜市立大学, 附属市民総合医療センター, 准教授 2015: 横浜市立大学, 付属市民総合医療センター, 准教授 2014: 横浜市立大学, 附属市民総合医療センター, 准教授 … More 2010: 北海道大学, 北海道大学病院, 助教 2010: Hokkaido University, 病院, 助教 2009: Hokkaido University, 大学病院, 助教 2008: Hokkaido University, 病院, 助教 Less
Review Section/Research Field	Principal Investigator Gastroenterology / Basic Section 53010:Gastroenterology-related Except Principal Investigator Gastroenterology
Keywords	Principal Investigator 分子標的治療 / 肝癌 / CD8陽性T細胞 / 免疫 / IKK / β-catenin / CD8+T細胞 / 抗 PD-L1抗体治療 / バイオマーカー / 免疫チェックポイント阻害剤 … More / 肝細胞癌 / 脂肪性肝炎 / 酸化ストレス / ストレス関連遺伝子 / Heat shock factor / HSF1 / 肝癌発生 / 網羅的探索 / マイクロアレイ / RBM5 / RNA結合タンパク / 癌進展 … More Except Principal Investigator real-time PCR法 / real-time PCR / ペプチド核酸 / MGBプローブ / 核酸アナログ / 変異株定量 / 変異株 / 薬剤耐性 / 肝炎ウイルス Less

Examination of immunotherapy improvement through CD8+ T cell induction of refractory hepatocellular carcinoma and, construction of biomarkers.Principal Investigator
- Principal Investigator
  
  Chuma Makoto
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  Yokohama City University
Investigation of the HSF1 signaling pathway as the molecular targeted therapies for hepatocellular carcinoma.Principal Investigator
- Principal Investigator
  
  Makoto Chuma
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Yokohama City University
Molecular Screening by Microarray analysis for Hepatocarcinogenesis.Principal Investigator
- Principal Investigator
  
  CHUMA Makoto
- Project Period (FY)
  2008 – 2010
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Hokkaido University
The development of a quantitative assay of a single-nucleotide mutant of drug-resistant hepatitis virus.
- Principal Investigator
  
  HIGE Shuhei
- Project Period (FY)
  2008 – 2010
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Hokkaido University

All 2022 2021 2016 2015 2014 2011 2010 2009 2008

All Journal Article Presentation Book

[Book] Heat shock factor2015
- Author(s)
  Chuma M
- Total Pages
  8
- Publisher
  Springer
- Data Source
  KAKENHI-PROJECT-26460982
[Book] HSF supports cancer2015
- Author(s)
  Chuma M
- Total Pages
  20
- Publisher
  Springer
- Data Source
  KAKENHI-PROJECT-26460982
[Journal Article] Impact of psoas muscle index assessed by a simple measurement method on tolerability and duration of continued treatment with sorafenib in hepatocellular carcinoma patients2022
- Author(s)
  Ogushi Katsuaki、Chuma Makoto、Numata Kazushi、Nozaki Akito、Moriya Satoshi、Uojima Haruki、Kondo Masaki、Morimoto Manabu、Maeda Shin
- Journal Title
  
  European Journal of Gastroenterology & Hepatology
  
  Volume: Publish Ahead of Print Issue: 7 Pages: 1-1
- DOI
  10.1097/meg.0000000000002346
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K08425, KAKENHI-PROJECT-21K07899
[Journal Article] The change rate in serum nitric oxide may affect lenvatinib therapy in hepatocellular carcinoma.2022
- Author(s)
  Kawamura A, Uojima H, Chuma M, Shao X, Hidaka H, Nakazawa T, Take A, Sakaguchi Y, Numata K, Kako M, Nozaki A, Azuma S, Horio K, Kusano C, Atsuda K
- Journal Title
  
  BMC Cancer
  
  Volume: 22 Issue: 1 Pages: 912-921
- DOI
  10.1186/s12885-022-10002-x
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07899, KAKENHI-PROJECT-22K07074
[Journal Article] EGFR inhibition reverses resistance to lenvatinib in hepatocellular carcinoma cells2022
- Author(s)
  He Xiaoping、Hikiba Yohko、Suzuki Yoshimasa、Nakamori Yoshinori、Kanemaru Yushi、Sugimori Makoto、Sato Takeshi、Nozaki Akito、Chuma Makoto、Maeda Shin
- Journal Title
  
  Scientific Reports
  
  Volume: 12 Issue: 1 Pages: 8007-8007
- DOI
  10.1038/s41598-022-12076-w
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K08425, KAKENHI-PROJECT-21K07899
[Journal Article] Identification of CT Values That Could Be Predictive of Necrosis (N-CTav) in Hepatocellular Carcinoma after Lenvatinib Treatment2022
- Author(s)
  Makoto Chuma, Hideki Yokoo, Atsushi Hiraoka, Kazuhiko Ueda, et al.
- Journal Title
  
  Current Oncology
  
  Volume: - Issue: 5 Pages: 3259-3271
- DOI
  10.3390/curroncol29050266
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07899
[Journal Article] A prospective observational cohort study of lenvatinib as initial treatment in patients with BCLC-defined stage B hepatocellular carcinoma2022
- Author(s)
  Kobayashi S, Fukushima T, Ueno M, Moriya S, Chuma M, Numata K, Tsuruya K, Hirose S, Kagawa T, Hattori N, Watanabe T, Matsunaga K, Suzuki M, Uojima H, Hidaka H, Kusano C, Suzuki M, Morimoto M.
- Journal Title
  
  BMC Cancer
  
  Volume: 22 Issue: 1 Pages: 517-517
- DOI
  10.1186/s12885-022-09625-x
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07899
[Journal Article] NAFLD exacerbates cholangitis and promotes cholangiocellular carcinoma in mice.2021
- Author(s)
  Maeda S, Hikiba Y, Fujiwara H, Ikenoue T, Sue S, Sugimori M, Matsubayashi M, Kaneko H, Irie K, Sasaki T, Chuma M
- Journal Title
  
  Cancer Sci,
  
  Volume: 12 Issue: 4 Pages: 1471-1480
- DOI
  10.1111/cas.14828
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07899, KAKENHI-PROJECT-21K07975
[Journal Article] Analysis of efficacy of lenvatinib treatment in highly advanced hepatocellular carcinoma with tumor thrombus in the main trunk of the portal vein or tumor with more than 50% liver occupation: A multicenter analysis.2021
- Author(s)
  1.Chuma M, Uojima H, Hiraoka A, et al.
- Journal Title
  
  Hepatology Research
  
  Volume: 51 Issue: 2 Pages: 201-215
- DOI
  10.1111/hepr.13592
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K07899
[Journal Article] Safety and efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma in early clinical practice: A multicenter analysis2021
- Author(s)
  Chuma Makoto、Hattori Nobuhiro、Watanabe Tsunamasa、Maeda Shin
- Journal Title
  
  Hepatology Research
  
  Volume: 52 Issue: 3 Pages: 269-280
- DOI
  10.1111/hepr.13732
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K08451, KAKENHI-PROJECT-21K07899
[Journal Article] Anti-adipogenic and antiviral effects of l-carnitine on hepatitis C virus infection.2016
- Author(s)
  Tsukuda Y, Suda G, Tsunematsu S, Ito J, Sato F, Terashita K, Nakai M, Sho T, Maehara O, Shimazaki T, Kimura M, Morikawa K, Natsuizaka M, Ogawa K, Ohnishi S, Chuma M, Sakamoto N
- Journal Title
  
  J Med Virol
  
  Volume: 89 Issue: 5 Pages: 857-866
- DOI
  10.1002/jmv.24692
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-16H05282, KAKENHI-PROJECT-26460982, KAKENHI-PROJECT-26461021, KAKENHI-PROJECT-15K08943, KAKENHI-PROJECT-15K08980, KAKENHI-PROJECT-16K09334, KAKENHI-PROJECT-16K15420
[Journal Article] ZEB1 expression is associated with prognosis of intrahepatic cholangiocarcinoma2016
- Author(s)
  Terashita K, Chuma M, Hatanaka Y, Hatanaka K, Mitsuhashi T, Yokoo H, Ohmura T, Ishizu H, Muraoka S, Nagasaka A, Tsuji T, Yamamoto Y, Kurauchi N, Shimoyama N, Toyoda H, Kumada T, Kaneoka Y, Maeda A, Ogawa K, Natsuizaka M, Kamachi H, Kakisaka T, Kamiyama T, Taketomi A, Matsuno Y, Sakamoto N
- Journal Title
  
  J Clin Pathol
  
  Volume: in press Issue: 7 Pages: 593-599
- DOI
  10.1136/jclinpath-2015-203115
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K08980, KAKENHI-PROJECT-25460449, KAKENHI-PROJECT-24590674, KAKENHI-PROJECT-26670375, KAKENHI-PROJECT-26460982, KAKENHI-PROJECT-15K08943, KAKENHI-PROJECT-16K08684
[Journal Article] Intratumoral artery on contrast-enhanced computed tomography imaging: differentiating intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma2015
- Author(s)
  Tsunematsu S, Chuma M, Kamiyama T, Miyamoto N, Yabusaki S, Hatanaka K, Mitsuhashi T, Kamachi H, Yokoo H, Kakisaka T, Tsuruga Y, Orimo T, Wakayama K, Ito J, Sato F, Terashita K, Nakai M, Tsukuda Y, Sho T, Suda G, Morikawa K, Natsuizaka M, Nakanishi M, Ogawa K, Taketomi A, Matsuno Y, Sakamoto N
- Journal Title
  
  Abdom Imaging
  
  Volume: 40 Issue: 6 Pages: 1492-9
- DOI
  10.1007/s00261-015-0352-9
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K08980, KAKENHI-PROJECT-26460982, KAKENHI-PROJECT-26461021
[Journal Article] New molecularly targeted therapies against advanced hepatocellular carcinoma: From molecular pathogenesis to clinical trials and future directions.2015
- Author(s)
  Chuma M, Terashita K, Sakamoto N
- Journal Title
  
  Hepatol Res
  
  Volume: 印刷中 Issue: 10
- DOI
  10.1111/hepr.12459
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-26670375, KAKENHI-PROJECT-26460982
[Journal Article] Heat shock factor 1 accelerates hepatocellular carcinoma development by activating nuclear factor κB/mitogen-activated protein kinase.2014
- Author(s)
  Chuma M, Sakamoto N, Nakai A, Hige S, Nakanishi M, Natsuizaka M, Suda G, Sho T, Hatakaka K, Matsuno Y, Yokoo H, Kamiyama T, Taketomi A, Fujii G, Tashiro K, Hikiba Y, Fujimoto M, Asaka M, Maeda S
- Journal Title
  
  Carcinogenesis
  
  Volume: Epub ahead of print Issue: 2 Pages: 272-281
- DOI
  10.1093/carcin/bgt343
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24659359, KAKENHI-PROJECT-25440010, KAKENHI-PROJECT-25860512, KAKENHI-PROJECT-25860513, KAKENHI-PROJECT-26460982
[Journal Article] p53 transactivation is involved in the antiproliferative activity of the putative tumor suppressor RBM5.2011
- Author(s)
  Kobayashi T, Ishida J, Musashi M, Ota S, Yoshida T, Shimizu Y, Chuma M, Kawakami H, Asaka M, Tanaka J, Imamura M, Kobayashi M, Itoh H, Edamatsu H, Sutherland LC, Brachmann RK.
- Journal Title
  
  Int J Cancer. 128(2)
  
  Pages: 304-318
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590752
[Journal Article] Sensitive Assay for Quantification of Hepatitis B Virus Mutants by Use of a Minor Groove Binder Probe and Peptide Nucleic Acids.2010
- Author(s)
  Shubei Hige, Yoichi Yamamoto, Shigeru Yoshida, Tomoe Kobayashi, Hiromasa Horimoto, Keiko Yamamoto, Takuya Sho, Mitsuteru Natsuizaka, Mitsuru Nakanishi, Makoto Chuma, Masahiro Asaka
- Journal Title
  
  Journal of Clinical Microbiology. 48
  
  Pages: 4487-4494
- NAID
  120003043348
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590753
[Journal Article] The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma.2009
- Author(s)
  Chuma M, Hige S, Kamiyama T, Meguro T, Nagasaka A, Nakanishi K, Yamamoto Y, Nakanishi M, Kohara T, Sho T, Yamamoto K, Horimoto H, Kobayashi T, Yokoo H, Matsushita M, Todo S, Asaka M.
- Journal Title
  
  J Gastroenterol. 44(9)
  
  Pages: 991-999
- NAID
  10025581551
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590752
[Journal Article] The influence of hepatitis B DNA level and antiviral therapy on recurrence afterinitial curative treatment in patients with hepatocellular carcinoma.2009
- Author(s)
  Chuma M
- Journal Title
  
  J Gastroenterol. 23
  
  Pages: 991-999
- NAID
  10025581551
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590752
[Journal Article] 8-OHdG is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection2008
- Author(s)
  Chuma M
- Journal Title
  
  J Gastroenterol Hepatol. 23
  
  Pages: 1431-1436
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590752
[Journal Article] 8-OHdG is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.2008
- Author(s)
  Chuma M, Hige S, Nakanishi M, Ogawa K, Natsuizaka M, Yamamoto Y, Asaka M.
- Journal Title
  
  J Gastroenterol Hepatol. 23(9)
  
  Pages: 1431-1436
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590752
[Presentation] Safety and efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma in early clinical practice: A multicenter analysis.2022
- Author(s)
  Chuma M, Uojima H, Hattori N, Arase Y, Fukushima T, Hirose S, Hidaka H, Morimoto M, Numata K, Kagawa T, Maeda S
- Organizer
  30th. United European Gastroenterology
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07899
[Presentation] 切除不能肝細胞癌におけるAtezolizumab+Bevacizumabの安全性、有効性に関する多施設共同研究2022
- Author(s)
  中馬誠, 魚嶋晴紀, 福島泰斗
- Organizer
  第58回日本肝臓学会総会
- Data Source
  KAKENHI-PROJECT-21K07899
[Presentation] Circulating microRNA-1246 as a Possible Biomarker for Early Tumor Recurrence of Hepatocellular Carcinoma.2022
- Author(s)
  Chuma M, Toyoda H, Yokoo H, Nozaki A, Ogushi K, Tada T, Ogawa K, Numata K, Kumada T, Taketomi A, Naoya S, Maeda S
- Organizer
  Asian Pacific Association for the Study of the Liver (APASL) Oncology
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07899
[Presentation] 肝細胞癌の免疫療法+分子標的治療の実臨床における成績と効果関連バイオマーカーの選定2022
- Author(s)
  中馬誠, 加川建弘, 豊田秀徳
- Organizer
  第30回日本消化器関連学会週間 (JDDW2022)
- Data Source
  KAKENHI-PROJECT-21K07899
[Presentation] Identification of CT Values That Could Be Predictive of Necrosis (N-CTav) in Hepatocellular Carcinoma after Lenvatinib Treatment2022
- Author(s)
  Chuma M, Yokoo H, Hiraoka A, Ueda K, Tsuji K, Shimada N, Uojima H, Kobayashi S, Hattori N, Okubo T, Atsukawa M, Ishikawa T, Toyoda H, Tada T, Saito Y, Hidaka H, Morimoto M, Numata K, Kagawa T, Sakamoto M, Kumada T
- Organizer
  30th. United European Gastroenterology
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07899
[Presentation] 進行肝癌におけるアテゾリズマブ/ベバシズマブの治療効果、安全性に関する多施設共同研究2021
- Author(s)
  中馬誠, 森本学, 加川建弘
- Organizer
  第29回日本消化器関連学会週間 (JDDW2021)
- Data Source
  KAKENHI-PROJECT-21K07899
[Presentation] 進行肝癌に対するAtezolizumab+Bevacizumabの初期治療成績2021
- Author(s)
  中馬誠, 魚嶋晴紀, 服部伸洋
- Organizer
  第57回日本肝臓学会総会
- Data Source
  KAKENHI-PROJECT-21K07899
[Presentation] Molecular Pathogenesis for HCC Development: HSF1 Potential Molecular Target for HCC Therapies2016
- Author(s)
  Chuma M, Sakamoto N, Yokoo H, Kamiyama T, Taketomi A, Maeda S.
- Organizer
  The 25th Asian Pacific Association for the Study of the Liver
- Place of Presentation
  Tokyo
- Year and Date
  2016-02-22
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26460982
[Presentation] 肝細胞癌の早期再発予測に関する血清バイオマーカー2014
- Author(s)
  中馬　誠、坂本　直哉、神山　俊哉
- Organizer
  第50回肝臓学会総会
- Place of Presentation
  東京
- Year and Date
  2014-05-30
- Data Source
  KAKENHI-PROJECT-26460982
[Presentation] 肝細胞癌根治後の再発に関するHBV-DNA量、抗ウイルス薬の影響2010
- Author(s)
  中馬誠
- Organizer
  第38回日本肝臓学会東部会
- Place of Presentation
  東京
- Year and Date
  2010-12-02
- Data Source
  KAKENHI-PROJECT-20590752
[Presentation] 肝細胞癌根治後の再発に関するHBV-DNA量、抗ウイルス薬の関与2009
- Author(s)
  中馬誠
- Organizer
  第45回日本肝臓学会総会
- Place of Presentation
  神戸
- Year and Date
  2009-06-05
- Data Source
  KAKENHI-PROJECT-20590752
[Presentation] The Influence of Hepatitis B DNA Level and Antiviral Therapy on Recurrence After Initial Curative Treatment in Patients With Hepatocellular Carcinoma.2009
- Author(s)
  Chuma M.
- Organizer
  第19回アジア太平洋肝臓学会
- Place of Presentation
  香港
- Year and Date
  2009-02-15
- Data Source
  KAKENHI-PROJECT-20590752
[Presentation] 8-OHdG is a risk factor for development of hepatocellular carcinoma in natients with chronic hepatitis C virus infection2008
- Author(s)
  Chuma M
- Organizer
  第43回欧州肝臓学会
- Place of Presentation
  イタリア・ミラノ
- Data Source
  KAKENHI-PROJECT-20590752
[Presentation] 8-OHdG is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.2008
- Author(s)
  Chuma M.
- Organizer
  第43回欧州肝臓学会
- Place of Presentation
  ミラノ
- Year and Date
  2008-04-25
- Data Source
  KAKENHI-PROJECT-20590752

1. KOBAYASHI Takahiko (80333607)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
2. HIGE Shuhei (70261295)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
3. 坂本直哉 (10334418)

# of Collaborated Projects: 1 results

# of Collaborated Products: 7 results
4. 前田愼 (40415956)

# of Collaborated Projects: 1 results

# of Collaborated Products: 5 results
5. 魚嶋晴紀 (20752869)

# of Collaborated Projects: 1 results

# of Collaborated Products: 7 results
6. WATANABE Tsunamasa

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
7. 須田剛生

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
8. 小川浩司

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
9. 近藤正晃

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
10. 中西満

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
11. 森川賢一

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
12. 大西俊介

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Chuma Makoto 中馬 誠

Makoto Chuma 中馬 誠

CHUMA Makoto 中馬 誠

Research Projects

Research Products

Co-Researchers

Examination of immunotherapy improvement through CD8+ T cell induction of refractory hepatocellular carcinoma and, construction of biomarkers.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Investigation of the HSF1 signaling pathway as the molecular targeted therapies for hepatocellular carcinoma.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Molecular Screening by Microarray analysis for Hepatocarcinogenesis.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

The development of a quantitative assay of a single-nucleotide mutant of drug-resistant hepatitis virus.

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Book] Heat shock factor2015

Author(s)

Total Pages

Publisher

Data Source

[Book] HSF supports cancer2015

Author(s)

Total Pages

Publisher

Data Source

[Journal Article] Impact of psoas muscle index assessed by a simple measurement method on tolerability and duration of continued treatment with sorafenib in hepatocellular carcinoma patients2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] The change rate in serum nitric oxide may affect lenvatinib therapy in hepatocellular carcinoma.2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] EGFR inhibition reverses resistance to lenvatinib in hepatocellular carcinoma cells2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Identification of CT Values That Could Be Predictive of Necrosis (N-CTav) in Hepatocellular Carcinoma after Lenvatinib Treatment2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] A prospective observational cohort study of lenvatinib as initial treatment in patients with BCLC-defined stage B hepatocellular carcinoma2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] NAFLD exacerbates cholangitis and promotes cholangiocellular carcinoma in mice.2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Analysis of efficacy of lenvatinib treatment in highly advanced hepatocellular carcinoma with tumor thrombus in the main trunk of the portal vein or tumor with more than 50% liver occupation: A multicenter analysis.2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Safety and efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma in early clinical practice: A multicenter analysis2021

Author(s)

Journal Title

DOI

Data Source

Chuma Makoto 中馬誠

Makoto Chuma 中馬誠

CHUMA Makoto 中馬誠